Article

COVID-19: BELKIN Laser CEO offers company update

Author(s):

Alex Delaney-Gesing

Daria Lemann-Blumenthal, CEO of BELKIN Laser Ltd, provides an update on how the company's operations have continued to progress amid the coronavirus pandemic.

 

See more coronavirus coverage here

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
January 9th 2025

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals
January 7th 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
December 11th 2024

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

© 2025 MJH Life Sciences

All rights reserved.